NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-128 Cr | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr | ₹11 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-128 Cr |
| Mar2024 | ₹-205 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-119 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-128 Cr | Negative | |
| Mar2024 | ₹-205 Cr | Negative | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-119 Cr | Negative | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹219.0 Cr | 6.6% | 2.1% | -15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 6.6% |
2.1% |
-15.6% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses